- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03659526
Quantitative Stress Echocardiography to Diagnose Myocardial Ischaemia (DEVISE)
Development, Validation and Implementation of a New Quantitative Stress Echocardiographic Test for Myocardial Ischaemia
Patients with chest pain on exertion need a reliable non-invasive test to identify if they have inducible myocardial ischaemia. This would reduce the use of diagnostic coronary arteriography, avoid its risks and costs, and guide clinical decisions. Conventional stress echocardiography has poor reproducibility because it relies on qualitative and subjective interpretation. Quantitative approaches based on precise and reliable measurements of myocardial velocity, strain, strain rate and global longitudinal strain have been shown to be able to accurately diagnose myocardial ischaemia. A more accurate test using myocardial velocity imaging was not implemented by ultrasound vendors although it provided an objective measurement of myocardial functional reserve on a continuous scale from normality to severe ischaemia.
The investigators propose an original approach to create a diagnostic software tool that can be used in routine clinical practice. The investigators will extract and compare quantitative data obtained through myocardial velocity imaging and speckle tracking in subjects who undergo dobutamine stress echocardiography.
The data will be analysed using advanced computational mathematics including multiple kernel learning and joint statistics applied to multivariate data across multiple dimensions (including velocity, strain and strain rate traces). This approach will be validated against quantitative coronary arteriography and fractional flow reserve. The results will be displayed as parametric images and placed into a reporting tool. The output will determine the presence and severity of myocardial ischaemia. These new tools will have the capacity for iterative learning so that the precision of the diagnostic conclusions can be continuously refined.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Imran D Sunderji
- Phone Number: +441482 875875
- Email: imran.sunderji@nhs.net
Study Contact Backup
- Name: Alan G Fraser
Study Locations
-
-
-
Leuven, Belgium
- Not yet recruiting
- UZ Leuven
-
Contact:
- Jens Voigt
-
-
-
-
-
Stockholm, Sweden
- Not yet recruiting
- Danderyd Hospital
-
Contact:
- Reidar Winter
-
-
-
-
-
Cardiff, United Kingdom
- Recruiting
- University Hospital Wales
-
Contact:
- Alan G Fraser
-
Principal Investigator:
- Alan G Fraser
-
Cottingham, United Kingdom
- Not yet recruiting
- Castle Hill Hospital
-
Contact:
- Imran D Sunderji
-
Principal Investigator:
- Imran D Sunderji
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Chest pain, chest pain equivalent
Exclusion Criteria:
- acute coronary syndrome with elevated troponin, severe heart valve disease, uncontrolled hypertension (resting SBP >200mmHg), cardiomyopathy, contraindication to dobutamine, pregnancy
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Control
Healthy volunteers or if they have had normal invasive or CT coronary arteriography or other functional imaging test
|
Deformation parameters derived using myocardial velocity imaging or speckle tracking
|
Deformation imaging
Significant coronary disease (diameter stenosis >50%) has been diagnosed on arteriography or on CT angiography.
Fractional flow reserve will be measured as the reference criterion.
|
Deformation parameters derived using myocardial velocity imaging or speckle tracking
|
High p(CAD)
Intermediate-to-high probability of significant epicardial coronary disease (>50%).
|
Deformation parameters derived using myocardial velocity imaging or speckle tracking
|
All comers
Probability of severe disease ranging from 15 to 85%.
|
Deformation parameters derived using myocardial velocity imaging or speckle tracking
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Diagnostic accuracy of quantitative measures of dobutamine stress echocardiography
Time Frame: 18 months
|
Echocardiographic measurements of segmental myocardial velocity, strain, strain rate and wall motion scoring referenced against measurements derived from coronary angiography.
|
18 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Lowest dose of dobutamine to provoke measurable marker of inducible myocardial ischaemia
Time Frame: 18 months
|
Using modelling techniques applied predict lowest dose of dobutamine to maintain diagnostic accuracy
|
18 months
|
Diagnostic accuracy of using machine learning to interpret multiparametric and multidimensional datasets to diagnose myocardial ischaemia
Time Frame: 18 months
|
Use modelling to combine pre-test probabilities (based on risk factors such as age), physiological factors (e.g., heart rate) that are associated with longitudinal function and data derived throughout the cardiac cycle (i.e., based on analysis of velocity or strain curves and not just a single value like peak velocity or strain).
|
18 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Alan G Fraser, University Hospital Wales
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRAS Project ID 136434
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ischemia, Myocardial
-
Recardio, Inc.CompletedAcute Myocardial Infarction | STEMI - ST Elevation Myocardial Infarction | Acute Myocardial IschemiaNetherlands, Hungary, Austria, Poland, Belgium
-
University of Roma La SapienzaCompletedRosuvastatin in Preventing Myonecrosis in Elective Percutaneous Coronary Interventions (PCIs) (ROMA)Periprocedural Myocardial NecrosisItaly
-
Tomsk National Research Medical Center of the Russian...CompletedMyocardial Infarction | Myocardial Injury | STEMI | Myocardial NecrosisRussian Federation
-
Lokien van NunenMaquet Cardiovascular; Stichting Toegepaste Wetenschappen (project number 11052)CompletedAcute Myocardial Infarction | Persisting Ischemia | No ReflowNetherlands
-
University Hospital "Sestre Milosrdnice"CompletedSTEMI - ST Elevation Myocardial Infarction | Myocardial ReperfusionCroatia
-
Fundacio Privada Mon Clinic BarcelonaMiracor Medical SANot yet recruiting
-
University Hospital, ToulouseThoratec CorporationWithdrawnChronic Myocardial IschemiaFrance
-
Deutsches Herzzentrum MuenchenCompletedInfarction, MyocardialGermany
-
Barts & The London NHS TrustUniversity College, London; Queen Mary University of LondonCompletedAcute Myocardial InfarctionSwitzerland, Denmark, United Kingdom
-
Gennaro SardellaCompletedAssess the Periprocedural Myocardial NecrosisItaly
Clinical Trials on Deformation imaging
-
RWTH Aachen UniversityCompletedMyocardial Viability in Ischemic Left Ventricular Dysfunction | Prediction for Improvement in Cardiac Function After Revascularization TherapyGermany
-
Mayo ClinicTerminated
-
RWTH Aachen UniversityCompleted
-
Universitaire Ziekenhuizen KU LeuvenUnknown
-
University Hospital, BordeauxCompletedLeukemia | Cardiac ToxicityFrance
-
Ohio State University Comprehensive Cancer CenterNot yet recruitingLymphedema of the Head and NeckUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)WithdrawnUnspecified Adult Solid TumorUnited States
-
University of Wisconsin, MadisonTerminatedHead and Neck Cancer | Esophageal Cancer | Lung Cancer | Prostate Cancer | CNS Brain MetastasesUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedMRI | Prostate CancerUnited States
-
Hungarian Institute of CardiologyRecruitingAtrial FibrillationHungary